These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19497532)

  • 1. Regarding "Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study".
    Goldstein MR; Mascitelli L; Pezzetta F
    J Vasc Surg; 2009 Jun; 49(6):1632-3; author reply 1633. PubMed ID: 19497532
    [No Abstract]   [Full Text] [Related]  

  • 2. Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study.
    Al-Omran M; Mamdani MM; Lindsay TF; Melo M; Juurlink DN; Verma S;
    J Vasc Surg; 2008 Sep; 48(3):607-12. PubMed ID: 18585886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice-Level Variation in Statin Use Among Patients With Diabetes: Insights From the PINNACLE Registry.
    Pokharel Y; Gosch K; Nambi V; Chan PS; Kosiborod M; Oetgen WJ; Spertus JA; Ballantyne CM; Petersen LA; Virani SS
    J Am Coll Cardiol; 2016 Sep; 68(12):1368-9. PubMed ID: 27634128
    [No Abstract]   [Full Text] [Related]  

  • 4. Opportunities for deprescribing statins in patients with poor cancer prognosis.
    Turner J; Singhal N; Bell JS
    J Palliat Med; 2013 Nov; 16(11):1328. PubMed ID: 24053634
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of Statin Therapy for ASCVD.
    Luo J; Kesselheim AS
    JAMA; 2015 Nov; 314(20):2191. PubMed ID: 26599189
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness of Statin Therapy for ASCVD--Reply.
    Pandya A; Weinstein MC; Gaziano TA
    JAMA; 2015 Nov; 314(20):2191-2. PubMed ID: 26599190
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Patients.
    Okerson T; Patel J; DiMario S; Burton T; Seare J; Harrison DJ
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28314797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Starting statins for primary prevention of cardiovascular disease.
    Tunstall-Pedoe H
    Heart; 2013 Nov; 99(21):1547-8. PubMed ID: 23878178
    [No Abstract]   [Full Text] [Related]  

  • 9. All people over 75 years with a five-year CVD risk of ≥15% should be treated with statins unless specifically contraindicated: no.
    Mangin D
    J Prim Health Care; 2010 Dec; 2(4):333-5. PubMed ID: 21125076
    [No Abstract]   [Full Text] [Related]  

  • 10. Current 10-year atherosclerotic cardiovascular disease risk threshold for statin eligibility is cost-effective for primary prevention.
    Yeboah J
    Evid Based Med; 2015 Dec; 20(6):230. PubMed ID: 26337629
    [No Abstract]   [Full Text] [Related]  

  • 11. Prescribing statins in general practice: who decides?
    Steel N; Fleetcroft B; Hassan Y
    Br J Gen Pract; 2017 Jun; 67(659):246-247. PubMed ID: 28546390
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescribing Statins to Reduce Cardiovascular Disease: 10 Common Misconceptions.
    Schade DS; Shey L; Eaton RP
    Am J Med; 2019 Aug; 132(8):897-899. PubMed ID: 30851261
    [No Abstract]   [Full Text] [Related]  

  • 13. [Transferring to the practice the results of the clinical trials with statins: from the relative risk to the absolute risk].
    Martín-Luján F; Baldrich-Justel M; Bejarano-Romero F
    Med Clin (Barc); 2005 Dec; 125(20):799. PubMed ID: 16373038
    [No Abstract]   [Full Text] [Related]  

  • 14. Statin Prescribing Practices in the Comprehensive Care for HIV-Infected Patients.
    Kelly SG; Krueger KM; Grant JL; Penugonda S; Feinstein MJ; Taiwo BO; Achenbach CJ
    J Acquir Immune Defic Syndr; 2017 Sep; 76(1):e26-e29. PubMed ID: 28520617
    [No Abstract]   [Full Text] [Related]  

  • 15. [Statins: from data to routine prescription…].
    Vital Durand D
    Rev Med Interne; 2014 Mar; 35(3):151-3. PubMed ID: 24314846
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox.
    Ko DT; Mamdani M; Alter DA
    JAMA; 2004 Apr; 291(15):1864-70. PubMed ID: 15100205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Primary Care Appointment Times and Appropriate Prescribing of Statins for At-Risk Patients.
    Hare AJ; Adusumalli S; Park S; Patel MS
    JAMA Netw Open; 2021 May; 4(5):e219050. PubMed ID: 33974057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing cardiovascular risk factors: the gap between evidence and practice.
    Turnbull F
    PLoS Med; 2005 May; 2(5):e131. PubMed ID: 15916459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Under-prescription of statins in patients with non-alcoholic fatty liver disease.
    Del Ben M; Baratta F; Polimeni L; Pastori D; Loffredo L; Averna M; Violi F; Angelico F
    Nutr Metab Cardiovasc Dis; 2017 Feb; 27(2):161-167. PubMed ID: 27914698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.